Trial Profile
A phase I prevention study of atorvastatin in women at increased risk for breast cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Breast cancer; Ductal carcinoma
- Focus Biomarker; Pharmacodynamics
- 10 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
- 10 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
- 10 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.